IL1RAP-targeting CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL1RAP-targeting CAR-T cells, covering 2026-01-08 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma [Phase 1]